Joseph Hernandez
CIK 1598384 · Chief Executive Officer · last filed 2026-03-24
Joseph Hernandez is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 6 companies since 2020. The most recent filing, for BWIV.U, was dated Mar 24, 2026. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.45M
6
12
-$7.81M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BWIV.U | Chief Executive Officer | 275,000 | $10.06 | $2.77M | $0 | 1 | 2026-03-24 |
| BLUWW | Chief Executive Officer | 430,000 | $0.40 | $172.0K | $0 | 1 | 2025-11-28 |
| BLUWU | Chief Executive Officer | 430,000 | $10.50 | $4.51M | $0 | 1 | 2025-06-12 |
| Onconetix, Inc. (BWV) Delisted | CEO | 2,800,351 | $0.18 | $504.6K | -$2.64M | 3 | 2023-05-11 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Director | 1,308,266 | $0.01 | $17.8K | $0 | 3 | 2022-06-09 |
| OGEN | 10%+ Owner | 2,236 | $0.50 | $1.1K | -$5.17M | 2 | 2021-01-26 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-24 | BWIV.U | Buy (P) | +275,000 | $0 | EDGAR |
| 2025-11-28 | BLUWW | Mixed | −430,000 | $0 | EDGAR |
| 2025-06-12 | BLUWU | Buy (P) | +430,000 | $0 | EDGAR |
| 2023-05-11 | Onconetix, Inc. (BWV) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2022-08-22 | Onconetix, Inc. (BWV) Delisted | Sell (S) | −549,649 | -$2.64M | EDGAR |
| 2022-06-09 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +1,922 | $0 | EDGAR |
| 2022-05-27 | Onconetix, Inc. (BWV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-27 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Mixed | +1,172,500 | $0 | EDGAR |
| 2021-12-14 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +3,844 | $0 | EDGAR |
| 2021-09-13 | — | Mixed | +2,605,000 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.